TrialGynecologic oncology2022

A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial.

John H Farley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.